Ju-Hee Bang

484 total citations
17 papers, 380 citations indexed

About

Ju-Hee Bang is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Ju-Hee Bang has authored 17 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Ju-Hee Bang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Ju-Hee Bang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Ju-Hee Bang collaborates with scholars based in South Korea, United States and Puerto Rico. Ju-Hee Bang's co-authors include Do‐Youn Oh, Ah-Rong Nam, Yung‐Jue Bang, Ji Eun Park, Mei Hua Jin, Kyung-Hun Lee, Seock‐Ah Im, Sae‐Won Han, Tae‐Yong Kim and Mei Jin and has published in prestigious journals such as Blood, Scientific Reports and British Journal of Cancer.

In The Last Decade

Ju-Hee Bang

17 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju-Hee Bang South Korea 13 247 127 105 67 64 17 380
Corrado Gallo Stampino Italy 12 238 1.0× 183 1.4× 103 1.0× 33 0.5× 39 0.6× 31 419
Christopher Riley United States 8 177 0.7× 179 1.4× 117 1.1× 79 1.2× 145 2.3× 11 514
Benjamin J. Gigliotti United States 7 188 0.8× 106 0.8× 93 0.9× 34 0.5× 79 1.2× 18 392
Eric Cheung United States 11 244 1.0× 96 0.8× 112 1.1× 39 0.6× 57 0.9× 21 498
Sandra Gottschling Germany 11 189 0.8× 154 1.2× 107 1.0× 49 0.7× 91 1.4× 16 431
Nathalie Voorzanger‐Rousselot France 11 278 1.1× 298 2.3× 60 0.6× 36 0.5× 77 1.2× 13 545
Peter Houghton United States 8 150 0.6× 171 1.3× 165 1.6× 25 0.4× 42 0.7× 20 400
Ecaterina Ileana France 6 192 0.8× 335 2.6× 177 1.7× 76 1.1× 57 0.9× 9 567
Eirini Thanopoulou United Kingdom 12 148 0.6× 121 1.0× 158 1.5× 19 0.3× 24 0.4× 26 401
Hyuk‐Chan Kwon South Korea 9 146 0.6× 121 1.0× 139 1.3× 76 1.1× 13 0.2× 19 348

Countries citing papers authored by Ju-Hee Bang

Since Specialization
Citations

This map shows the geographic impact of Ju-Hee Bang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju-Hee Bang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju-Hee Bang more than expected).

Fields of papers citing papers by Ju-Hee Bang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju-Hee Bang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju-Hee Bang. The network helps show where Ju-Hee Bang may publish in the future.

Co-authorship network of co-authors of Ju-Hee Bang

This figure shows the co-authorship network connecting the top 25 collaborators of Ju-Hee Bang. A scholar is included among the top collaborators of Ju-Hee Bang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju-Hee Bang. Ju-Hee Bang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nam, Ah-Rong, et al.. (2021). WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers. Gastric Cancer. 24(5). 1003–1020. 25 indexed citations
2.
Nam, Ah-Rong, et al.. (2021). ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer. Cancer Letters. 516. 38–47. 18 indexed citations
3.
Park, Woo Chan, Ju-Hee Bang, Ah-Rong Nam, et al.. (2020). Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients. Cancer Research and Treatment. 53(1). 199–206. 12 indexed citations
4.
Jin, Mei, Ah-Rong Nam, Ji Eun Park, et al.. (2019). Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer. Cancer Research and Treatment. 52(1). 149–166. 30 indexed citations
5.
Park, Ji Eun, Mei Jin, Ah-Rong Nam, et al.. (2019). GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer. Gastric Cancer. 22(5). 932–940. 13 indexed citations
6.
Kim, Jin Won, Kyung-Hun Lee, Ji‐Won Kim, et al.. (2019). Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study. British Journal of Cancer. 121(4). 332–339. 25 indexed citations
7.
Park, Hyunkyung, Ju-Hee Bang, Ah-Rong Nam, et al.. (2019). Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer. Scientific Reports. 9(1). 11131–11131. 24 indexed citations
8.
Nam, Ah-Rong, Ji‐Won Kim, Ji Eun Park, et al.. (2018). Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer. Cancer Research and Treatment. 51(3). 886–900. 5 indexed citations
9.
Nam, Ah-Rong, Mei Hua Jin, Ji Eun Park, et al.. (2018). Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer. Cancer Research and Treatment. 51(3). 1167–1179. 26 indexed citations
10.
Ha, Hyerim, Ju-Hee Bang, Ah-Rong Nam, et al.. (2018). Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology. Cancer Research and Treatment. 51(2). 832–840. 14 indexed citations
11.
Jin, Mei Hua, Ah-Rong Nam, Ji Eun Park, et al.. (2017). Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition. Molecular Cancer Therapeutics. 16(6). 1145–1154. 47 indexed citations
12.
Nam, Ah-Rong, et al.. (2017). Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer. Cancer Letters. 411. 162–170. 11 indexed citations
13.
Nam, Ah-Rong, Ji‐Won Kim, Ji Eun Park, et al.. (2016). Src as a Therapeutic Target in Biliary Tract Cancer. Molecular Cancer Therapeutics. 15(7). 1515–1524. 9 indexed citations
14.
Ock, Chan-Young, Ah-Rong Nam, Joongyub Lee, et al.. (2016). Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer. Gastric Cancer. 20(2). 254–262. 51 indexed citations
15.
Ock, Chan-Young, Ah-Rong Nam, Ju-Hee Bang, et al.. (2015). Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer. Gastric Cancer. 20(1). 164–174. 16 indexed citations
16.
Hong, Ji Hyung, Sung‐Eun Lee, Soo Young Choi, et al.. (2014). Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia. Cancer Research and Treatment. 47(4). 937–942. 16 indexed citations
17.
Branford, Susan, David T Yeung, Soo-Young Choi, et al.. (2012). BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management. Blood. 119(18). 4264–4271. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corrado Gallo Stampino Breakdown of academic impact, for papers by Christopher Riley Breakdown of academic impact, for papers by Benjamin J. Gigliotti Breakdown of academic impact, for papers by Eric Cheung Breakdown of academic impact, for papers by Sandra Gottschling Breakdown of academic impact, for papers by Nathalie Voorzanger‐Rousselot Breakdown of academic impact, for papers by Peter Houghton Breakdown of academic impact, for papers by Ecaterina Ileana Breakdown of academic impact, for papers by Eirini Thanopoulou Breakdown of academic impact, for papers by Hyuk‐Chan Kwon
Rankless by CCL
2026